日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis

银屑病中的皮肤炎症、全身炎症和心血管疾病

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2024.4433
Svedbom, Axel; Mallbris, Lotus; González-Cantero, Álvaro; Playford, Martin; Wu, Colin; Mehta, Nehal N; Ståhle, Mona
炎症
炎症/感染
心血管疾病
银屑病
Immunology/Inflammation
心血管
发表日期：2025
文献求助 收藏

Interferon alpha promotes caspase-8 dependent ultraviolet light-mediated keratinocyte apoptosis via interferon regulatory factor 1

干扰素α通过干扰素调节因子1促进caspase-8依赖的紫外线介导的角质形成细胞凋亡

期刊:Frontiers in Immunology
影响因子:5.7
doi:10.3389/fimmu.2024.1384606
Shannon N Loftus, Mehrnaz Gharaee-Kermani, Bin Xu, Tyson M Moore, Andrew Hannoudi, Mischa J Mallbris, Benjamin Klein, Johann E Gudjonsson, J Michelle Kahlenberg
信号转导
细胞生物学
其它细胞
Apoptosis
发表日期：2024
文献求助 收藏

Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis

Lebrikizumab 可快速改善中重度特应性皮炎青少年和成人患者所有湿疹面积和严重程度指数（EASI）部位及临床体征的症状。

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-024-01158-4
Simpson, Eric L; de Bruin-Weller, Marjolein; Hong, H Chih-Ho; Staumont-Sallé, Delphine; Blauvelt, Andrew; Eyerich, Kilian; Gooderham, Melinda; Shahriari, Mona; Mallbris, Lotus; Atwater, Amber Reck; Rueda, Maria Jose; Ding, Yuxin; Liu, Zhuqing; Agell, Helena; Silverberg, Jonathan I
发表日期：2024
文献求助 收藏

Adult patients with alopecia areata report a significantly better medication adherence compared to those with atopic dermatitis: Results from a large cross-sectional cohort study

一项大型横断面队列研究的结果显示，斑秃成年患者的用药依从性明显优于特应性皮炎患者。

期刊:
影响因子:
doi:10.1016/j.jdin.2024.03.026
Mallbris, Mischa J; Nymand, Lea Krog; Andersen, Yuki Maria Fukuda; Egeberg, Alexander
发表日期：2024
文献求助 收藏

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis

治疗所需人数网络荟萃分析比较生物制剂治疗中重度银屑病的疗效

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-022-02065-w
Leonardi, Craig L; See, Kyoungah; Burge, Russel; Sun, Zhuoer; Zhang, Ying; Mallbris, Lotus; Garrelts, Alyssa; Warren, Richard B
银屑病
发表日期：2022
文献求助 收藏

Risk of respiratory infection in patients with plaque psoriasis

斑块状银屑病患者呼吸道感染风险

期刊:Journal of the American Academy of Dermatology
影响因子:11.8
doi:10.1016/j.jaad.2020.12.083
Svedbom, Axel; Mallbris, Lotus; Ståhle, Mona
炎症/感染
银屑病
发表日期：2021
文献求助 收藏

Long-term Outcomes and Prognosis in New-Onset Psoriasis

新发银屑病患者的长期疗效和预后

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2021.0734
Svedbom, Axel; Mallbris, Lotus; Larsson, Per; Nikamo, Pernilla; Wolk, Katarina; Kjellman, Petra; Sonkoly, Enikö; Eidsmo, Liv; Lindqvist, Ulla; Ståhle, Mona
银屑病
发表日期：2021
文献求助 收藏

Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool

结合医生和患者报告结果的银屑病严重程度评估：最佳银屑病评估工具

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-021-00544-6
Leonardi, Craig; See, Kyoungah; Gallo, Gaia; McKean-Matthews, Missy; Zhang, Ying; Goldblum, Orin; Mallbris, Lotus; Burge, Russel
银屑病
发表日期：2021
文献求助 收藏

A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies

一项用于评估银屑病疾病严重程度的多项目医师总体评估量表：基于四项托法替尼 III 期研究的验证

期刊:BMC Dermatology
影响因子:
doi:10.1186/s12895-019-0088-2
Callis Duffin, Kristina; Bushmakin, Andrew G; Cappelleri, Joseph C; Mallbris, Lotus; Mamolo, Carla
银屑病
发表日期：2019
文献求助 收藏

Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

更正：伊克珠单抗治疗依那西普无应答患者的疗效和安全性：两项中重度斑块状银屑病 III 期随机临床试验（UNCOVER-2 和 -3）的亚组分析

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-018-0353-x
Blauvelt, Andrew; Papp, Kim A; Griffiths, Christopher E M; Puig, Luis; Weisman, Jamie; Dutronc, Yves; Kerr, Lisa Farmer; Ilo, Dapo; Mallbris, Lotus; Augustin, Matthias
银屑病
发表日期：2018
文献求助 收藏